Generic Versus Branded Atorvastatin: A Single-Center Comparative Analysis of Clinical Effectiveness and Post-Delisting Cost Savings in Saudi Arabia

Abdulmajeed Hassan Jaafari, Abdulaziz Sami Al-Shwairkh, Miteb A. Alanazi, Abdullah M. Alhammad, Yazed Alruthia

Open source

DOI
10.3390/healthcare14182983
Published
2026-09-12
Container
Healthcare
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/healthcare14182983,
  title = {Generic Versus Branded Atorvastatin: A Single-Center Comparative Analysis of Clinical Effectiveness and Post-Delisting Cost Savings in Saudi Arabia},
  author = {Abdulmajeed Hassan Jaafari and Abdulaziz Sami Al-Shwairkh and Miteb A. Alanazi and Abdullah M. Alhammad and Yazed Alruthia},
  year = {2026},
  journal = {Healthcare},
  doi = {10.3390/healthcare14182983},
  url = {https://doi.org/10.3390/healthcare14182983}
}

RIS

TY  - JOUR
TI  - Generic Versus Branded Atorvastatin: A Single-Center Comparative Analysis of Clinical Effectiveness and Post-Delisting Cost Savings in Saudi Arabia
AU  - Abdulmajeed Hassan Jaafari
AU  - Abdulaziz Sami Al-Shwairkh
AU  - Miteb A. Alanazi
AU  - Abdullah M. Alhammad
AU  - Yazed Alruthia
PY  - 2026
JO  - Healthcare
DO  - 10.3390/healthcare14182983
UR  - https://doi.org/10.3390/healthcare14182983
ER  - 

APA

Jaafari, A. H., Al-Shwairkh, A. S., Alanazi, M. A., Alhammad, A. M., & Alruthia, Y. (2026). Generic Versus Branded Atorvastatin: A Single-Center Comparative Analysis of Clinical Effectiveness and Post-Delisting Cost Savings in Saudi Arabia. Healthcare. https://doi.org/10.3390/healthcare14182983

Source records